| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad8d85592a4b19b8201fabc25e567d8f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_733527a13136be9dd720cd4056b356ff |
| publicationDate |
2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007010527-A1 |
| titleOfInvention |
4-Anilino-3-quinolinecarbonitriles for the treatment of cancer |
| abstract |
The present invention is directed to a method of preventing treating and/or inhibiting cancer using compounds of formula (I): n nor a pharmaceutically acceptable salt thereof This invention is also directed to pharmaceutical compositions containing compounds of formula (I). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9421203-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107433391-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013187967-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7767678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007015767-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445496-B2 |
| priorityDate |
2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |